Home > Estimates of Funding for Various Research, Condition, and Disease Categories (RCDC) > Project Listing by Category

Project Listing by Category

Back to Estimates of Funding for Various Research, Condition, and Disease Categories (RCDC)

Click the column headings to sort project listings.

Category	Funding IC	Project Number	Sub Project #	Project Title	PI Name	Org Name	State / Country	Amount
Sickle Cell Disease	NINR	1K23NR010940-01A2		A Decision Support Tool for Adult Sickle Cell Emergency Department Patients	TANABE, PAULA	NORTHWESTERN UNIVERSITY	IL	$112,129
Sickle Cell Disease	NHLBI	1K23HL083089-01A2		Sickle Cell Disease: First steps toward understanding barriers to care for adults	LANZKRON, SOPHIE	JOHNS HOPKINS UNIVERSITY	MD	$140,130
Sickle Cell Disease	NHLBI	5K02HL078706-04		Nitrite and Nitric Oxide in Sickle Cell Blood	KIM-SHAPIRO, DANIEL	WAKE FOREST UNIVERSITY	NC	$103,680
Sickle Cell Disease	NHLBI	5K24HL074256-04		Arginine as Prophylactic Therapy in Sickle Cell Disease	STYLES, LORI	CHILDREN'S HOSPITAL & RES CTR AT OAKLAND	CA	$150,118
Sickle Cell Disease	NHLBI	5R01HL079370-04		Gene Delivery into Human Hematopoietic Cells	BANK, ARTHUR	COLUMBIA UNIVERSITY HEALTH SCIENCES	NY	$343,479
Sickle Cell Disease	NHLBI	5K23HL079003-04		Gene polymorphism in chronic sickle cell lung disease	KLINGS, ELIZABETH	BOSTON UNIVERSITY MEDICAL CAMPUS	MA	$127,359
Sickle Cell Disease	NHLBI	5R01HL024415-29		Beta-globin Transcriptional Regulation	ENGEL, JAMES	UNIVERSITY OF MICHIGAN AT ANN ARBOR	MI	$408,040
Sickle Cell Disease	NHLBI	5R01HL079295-03		Using Zinc Finger Nucleases to Stimulate Gene Targeting in HSC	PORTEUS, MATTHEW	UNIVERSITY OF TEXAS SW MED CTR/DALLAS	TX	$343,006
Sickle Cell Disease	NHLBI	2U54HL070587-06		Statistics and Data Management Center-Comprehensive Sickle Cell Centers	KESLER, KAREN	RHO FEDERAL SYSTEMS DIVISION, INC.	NC	$3,400,108
Sickle Cell Disease	NHLBI	1R01HL090921-01		Cell selection strategies for the gene therapy of the beta-hemoglobinopathies	LEBOULCH, PHILIPPE	BRIGHAM AND WOMEN'S HOSPITAL	MA	$424,226
Sickle Cell Disease	NHLBI	1U54HL090569-01	0001	Parent focused intervention to improve academic success in children	GOLDMAN, MARIA	UNIVERSITY OF MIAMI SCHOOL OF MEDICINE	FL	$227,627
Sickle Cell Disease	NHLBI	1U54HL090569-01	6862	Administrative Core	ARMSTRONG, FLOYD	UNIVERSITY OF MIAMI SCHOOL OF MEDICINE	FL	$87,248
Sickle Cell Disease	NHLBI	1R21HL091331-01		Experimental and theoretical multiscale model of sickle cell vaso-occlusion in a	MAHADEVAN, L	HARVARD UNIVERSITY	MA	$231,950
Sickle Cell Disease	NINDS	5U01NS042804-05		Silent Cerebral Infarct Multi-Center Clinical Trial	DEBAUN, MICHAEL	WASHINGTON UNIVERSITY	MO	$3,509,378
Sickle Cell Disease	NHLBI	2R01HL068802-05A2		Opioid Activity in Endothelium in Sickle Cell Disease	GUPTA, KALPNA	UNIVERSITY OF MINNESOTA TWIN CITIES	MN	$391,250
Sickle Cell Disease	NHLBI	1R01HL086691-01A1		Improvement of communication process and outcomes after newborn genetic screening	FARRELL, MICHAEL	MEDICAL COLLEGE OF WISCONSIN	WI	$407,627
Sickle Cell Disease	NHLBI	2R01HL069438-05A2		Adhesion mechanisms mediating sickle cell vasoocclusion in vivo	FRENETTE, PAUL	MOUNT SINAI SCHOOL OF MEDICINE OF NYU	NY	$423,750
Sickle Cell Disease	NIDDK	2R01DK067223-04		eNOS Regulatory Mechanisms in Penile Vascular Function	BURNETT, ARTHUR	JOHNS HOPKINS UNIVERSITY	MD	$348,500
Sickle Cell Disease	NHLBI	5R37HL058091-12		Effects of Nitric Oxide in Sickle Cell Blood	KIM-SHAPIRO, DANIEL	WAKE FOREST UNIVERSITY	NC	$339,144
Sickle Cell Disease	NHLBI	5R01HL057549-11		Heterogenous Nucleation in Sickle Cell Disease	FERRONE, FRANK	DREXEL UNIVERSITY	PA	$254,888
Sickle Cell Disease	NINDS	5K24NS048323-05		Cerebrovascular Disease in Sickle Cell Anemia	LERNER, NORMA	UNIVERSITY OF ROCHESTER	NY	$120,711
Sickle Cell Disease	NHLBI	5R01HL081497-03		Genetic Determinants of Erythrocyte Hydration	BRUGNARA, CARLO	CHILDREN'S HOSPITAL BOSTON	MA	$577,636
Sickle Cell Disease	NHLBI	5R01HL081139-03		HDL Dysfunction and Vascular Inflammation	PRITCHARD, KIRKWOOD	MEDICAL COLLEGE OF WISCONSIN	WI	$367,766
Sickle Cell Disease	NHLBI	5U10HL083698-03		Duke-UNC Sickle Cell Disease Clinical Research Network	SCHULMAN, KEVIN	DUKE UNIVERSITY	NC	$150,108
Sickle Cell Disease	NHLBI	5U10HL083699-03		Atlanta Sickle Cell Disease Clinical Research Consortium	LANE, PETER	EMORY UNIVERSITY	GA	$162,812
Sickle Cell Disease	NHLBI	5R25HL084665-03		Short-term training program to increase diversity in health related research	DELISSER, HORACE	UNIVERSITY OF PENNSYLVANIA	PA	$64,736
Sickle Cell Disease	NHLBI	5U10HL083704-03		Northern California Consortium for Sickle Cell Disease	WALTERS, MARK	CHILDREN'S HOSPITAL & RES CTR AT OAKLAND	CA	$134,901
Sickle Cell Disease	NHLBI	5U10HL083732-03		Virginia Commonwealth University Sickle Cell Disease Clinical Network	SMITH, WALLY	VIRGINIA COMMONWEALTH UNIVERSITY	VA	$301,166
Sickle Cell Disease	NHLBI	5U10HL083721-03		Data Coordinating Center for the Sickle Cell Disease Clinical Research Network	MCKINLAY, SONJA	NEW ENGLAND RESEARCH INSTITUTES, INC.	MA	$5,622,379
Sickle Cell Disease	NHLBI	5R01HL083276-02		Vitamin B6, Vascular Dysfunction and Adhesion Molecules in Sickle Cell Disease	GREEN, RALPH	UNIVERSITY OF CALIFORNIA DAVIS	CA	$263,470
Sickle Cell Disease	OD	5R01HL083276-02		Vitamin B6, Vascular Dysfunction and Adhesion Molecules in Sickle Cell Disease	GREEN, RALPH	UNIVERSITY OF CALIFORNIA DAVIS	CA	$100,000
Sickle Cell Disease	NHLBI	5U10HL083748-03		Howard-CNMC Sickle Cell Disease Clinical Center	GORDEUK, VICTOR	HOWARD UNIVERSITY	DC	$163,184
Sickle Cell Disease	NHLBI	1F31HL091728-01		Psychosocial Functioning in Pediatric Sickle Cell Disease	LIM, CRYSTAL	GEORGIA STATE UNIVERSITY	GA	$34,572
Sickle Cell Disease	NHLBI	5U10HL083705-03		Marian Anderson Sickle Cell Center-Sickle Cell Disease Clinical Research Network	HSU, LEWIS	DREXEL UNIVERSITY	PA	$155,368
Sickle Cell Disease	NHLBI	5U10HL083730-03		Chicago Sickle Cell Clinical Network	DESIMONE, JOSEPH	UNIVERSITY OF ILLINOIS AT CHICAGO	IL	$147,651
Sickle Cell Disease	NHLBI	5U10HL083746-03		Sickle Cell Disease Clinical Research Network	OHENE-FREMPONG, KWAKU	CHILDREN'S HOSPITAL OF PHILADELPHIA	PA	$177,305
Sickle Cell Disease	NICHD	1R03HD057740-01		Pilot study of Newborn screening for hemoglobinopathies in South Gujarat India	KRISHNAMURTI, LAKSHMANAN	CHILDREN'S HOSP PITTSBURGH/UPMC HLTH SYS	PA	$88,759
Sickle Cell Disease	NHLBI	5K23HL077684-03		Pharmacogenetics of Pediatric Sickle Cell Disease	NEVILLE, KATHLEEN	CHILDREN'S MERCY HOSP (KANSAS CITY, MO)	MO	$154,022
Sickle Cell Disease	NHLBI	5K23HL078819-02		Predictors of Cognitive Deficits in Sickle Cell Disease	STROUSE, JOHN	JOHNS HOPKINS UNIVERSITY	MD	$138,141
Sickle Cell Disease	NHLBI	5U10HL083771-03		Boston Sickle Cell Research Consortium	MCMAHON, LILLIAN	BOSTON MEDICAL CENTER	MA	$157,923
Sickle Cell Disease	NHLBI	2U54HL070588-06	0007	Acute Bone Turnover and Disordered Porphyrin Metabolism: Sickle Cell Pain	QUINN, CHARLES	UNIVERSITY OF TEXAS SW MED CTR/DALLAS	TX	$93,747
Sickle Cell Disease	NHLBI	2U54HL070588-06	6597	Administrative Core	BUCHANAN, GEORGE	UNIVERSITY OF TEXAS SW MED CTR/DALLAS	TX	$61,973
Sickle Cell Disease	NHLBI	1U54HL090515-01	0001	Public health systems and survival of children with Sickle Cell Disease	MINKOVITZ, CYNTHIA	JOHNS HOPKINS UNIVERSITY	MD	$175,419
Sickle Cell Disease	NHLBI	1U54HL090515-01	0002	Proteomics of silent cerebral infarction biomarker in Sickle Cell Disease	EVERETT, ALLEN	JOHNS HOPKINS UNIVERSITY	MD	$371,832
Sickle Cell Disease	NHLBI	1U54HL090515-01	0003	Priapism prevention program for patients with Sickle Cell Disease	BURNETT, ARTHUR	JOHNS HOPKINS UNIVERSITY	MD	$298,001
Sickle Cell Disease	NHLBI	1U54HL090515-01	6640	Administrative Core	CASELLA, JAMES	JOHNS HOPKINS UNIVERSITY	MD	$212,348
Sickle Cell Disease	NHLBI	1U54HL090511-01	0001	Impact of Blood Viscosity on Oxygen Delivery in humans with Sickle Cell Anemia	COATES, THOMAS	CHILDREN'S HOSPITAL LOS ANGELES	CA	$388,614
Sickle Cell Disease	NHLBI	1U54HL090511-01	6657	Administration Core	COATES, THOMAS	CHILDREN'S HOSPITAL LOS ANGELES	CA	$84,322
Sickle Cell Disease	NHLBI	1R01HL091759-01		Longitudinal SIT Trial Plasma Proteomic Biomarker Discovery and Validation in SCI	CASELLA, JAMES	JOHNS HOPKINS UNIVERSITY	MD	$402,238
Sickle Cell Disease	NHLBI	5R01HL087681-02		Genome-Wide Association Studies in Sickle Cell Anemia and in Centenarians	STEINBERG, MARTIN	BOSTON UNIVERSITY MEDICAL CAMPUS	MA	$841,212
Sickle Cell Disease	NHLBI	1U54HL090513-01	0001	Tailored education for informed preproductive decisions in sickle cell disease	GALLO, AGATHA	UNIVERSITY OF ILLINOIS AT CHICAGO	IL	$1,430,273
Sickle Cell Disease	NHLBI	5R01HL079916-05		Role of Placenta Growth factor in Sickle ACS	PUNAM, MALIK	CHILDREN'S HOSPITAL MED CTR (CINCINNATI)	OH	$831,359
Sickle Cell Disease	NHLBI	5R01HL057619-11		Mouse Model of Sickle Cell Disease and Genetic Therapies	TOWNES, TIM	UNIVERSITY OF ALABAMA AT BIRMINGHAM	AL	$426,051
Sickle Cell Disease	NHLBI	5R01HL031579-28		Rheological and Adherence Properties of Sickle Cells	NARLA, MOHANDAS	NEW YORK BLOOD CENTER	NY	$355,022
Sickle Cell Disease	NHLBI	5R01HL077765-03		RBC Ion Transporters as Hemoglobinopathy Risk Modifiers	ALPER, SETH	BETH ISRAEL DEACONESS MEDICAL CENTER	MA	$390,245
Sickle Cell Disease	NHLBI	5R01HL079915-04		Pulmonary Hypertension in SCD	TELEN, MARILYN	DUKE UNIVERSITY	NC	$1,499,907
Sickle Cell Disease	NIDDK	5R01DK029902-27		Globin Gene Expression during Erythroid Differentiation	GINDER, GORDON	VIRGINIA COMMONWEALTH UNIVERSITY	VA	$299,341
Sickle Cell Disease	NHLBI	5K23HL079073-03		Educational Attainment in Sickle Cell Disease	KING, ALLISON	WASHINGTON UNIVERSITY	MO	$131,555
Sickle Cell Disease	NIA	5F30AG030909-02		Oxidative Stress & Inflammation in Aging: Insights from Sickle Cell Disease	BECKMAN, JOAN	UNIVERSITY OF MINNESOTA TWIN CITIES	MN	$32,964
Sickle Cell Disease	NIDDK	5R01DK073391-02		Erythroid Krupple-Like Factor Complexes Defined in TAP-Tagged Knockin Mice	TOWNES, TIM	UNIVERSITY OF ALABAMA AT BIRMINGHAM	AL	$359,874
Sickle Cell Disease	NHLBI	5R01HL079937-04		Asthma and Nocturnal Hypoxemia in Sickle Cell Anemia	DEBAUN, MICHAEL	WASHINGTON UNIVERSITY	MO	$1,841,516
Sickle Cell Disease	NHLBI	5R01HL078536-03		Computerized PAINRelievelt for Adult Sickle Cell Disease	WILKIE, DIANA	UNIVERSITY OF ILLINOIS AT CHICAGO	IL	$684,082
Sickle Cell Disease	NHLBI	1U54HL090569-01	0002	Scholar	ARMSTRONG, FLOYD	UNIVERSITY OF MIAMI SCHOOL OF MEDICINE	FL	$158,000
Sickle Cell Disease	NHLBI	2U54HL070588-06	0008	Sickle cell scholar program career development plan	BUCHANAN, GEORGE	UNIVERSITY OF TEXAS SW MED CTR/DALLAS	TX	$176,588
Sickle Cell Disease	NHLBI	1U54HL090515-01	0004	Sickle cell scholar component	CASELLA, JAMES	JOHNS HOPKINS UNIVERSITY	MD	$162,638
Sickle Cell Disease	NHLBI	1U54HL090511-01	0002	Sickle Cell Scholar Component	COATES, THOMAS	CHILDREN'S HOSPITAL LOS ANGELES	CA	$165,375
Sickle Cell Disease	NHLBI	1U54HL090508-01	0001	Niacin therapy to improve endothelial function in Sickle Cell Disease	LUBAN, NAOMI	CHILDREN'S NATIONAL MEDICAL CENTER	DC	$345,506
Sickle Cell Disease	NHLBI	1U54HL090508-01	7773	Administrative Core	GORDEUK, VICTOR	HOWARD UNIVERSITY	DC	$158,544
Sickle Cell Disease	NHLBI	1U54HL090508-01	0002	Sickle Cell Scholar Component	GORDEUK, VICTOR	HOWARD UNIVERSITY	DC	$161,655
Sickle Cell Disease	NHLBI	1U54HL090503-01	0001	Patient services: Development of the PedsQL Sickle Cell Disease Module	PANEPINTO, JULIE	MEDICAL COLLEGE OF WISCONSIN	WI	$163,740
Sickle Cell Disease	NHLBI	1U54HL090503-01	0002	Cell free Hemoglobin, lipid oxidation and Nitric oxide in Sickle Cell Disease	HOGG, NEIL	MEDICAL COLLEGE OF WISCONSIN	WI	$337,769
Sickle Cell Disease	NHLBI	1U54HL090503-01	7781	Administrative Core	HILLERY, CHERYL	MEDICAL COLLEGE OF WISCONSIN	WI	$133,059
Sickle Cell Disease	NHLBI	1U54HL090503-01	0003	Sickle Cell Scholar	HILLERY, CHERYL	MEDICAL COLLEGE OF WISCONSIN	WI	$159,075
Sickle Cell Disease	NHLBI	2U54HL070871-06	0007	Patient services: Improving adherence to therapy for Sickle Cell Disease	MITCHELL, MONICA	CHILDREN'S HOSPITAL MED CTR (CINCINNATI)	OH	$161,466
Sickle Cell Disease	NHLBI	2U54HL070871-06	0008	Genetic manipulation of red cell volume regualtion	JOINER, CLINTON	CHILDREN'S HOSPITAL MED CTR (CINCINNATI)	OH	$428,406
Sickle Cell Disease	NHLBI	2U54HL070871-06	7789	Administrative Core	JOINER, CLINTON	CHILDREN'S HOSPITAL MED CTR (CINCINNATI)	OH	$155,522
Sickle Cell Disease	NHLBI	2U54HL070871-06	0006	Sickle Cell Scholar Component	JOINER, CLINTON	CHILDREN'S HOSPITAL MED CTR (CINCINNATI)	OH	$157,500
Sickle Cell Disease	NHLBI	1U54HL090516-01	7822	Administrative Core	SMITH, WALLY	VIRGINIA COMMONWEALTH UNIVERSITY	VA	$103,732
Sickle Cell Disease	NHLBI	1U54HL090516-01	0002	Career Development for a Sickle Cell Scholar	SMITH, WALLY	VIRGINIA COMMONWEALTH UNIVERSITY	VA	$156,451
Sickle Cell Disease	NHLBI	2U54HL070819-06	0005	Sickle Cell Disease G6PD	LEOPOLD, JANE	BOSTON MEDICAL CENTER	MA	$245,570
Sickle Cell Disease	NHLBI	2U54HL070819-06	7831	Administrative Core	STEINBERG, MARTIN	BOSTON MEDICAL CENTER	MA	$116,369
Sickle Cell Disease	NHLBI	2U54HL070819-06	0004	Sickle Cell Scholar	STEINBERG, MARTIN	BOSTON MEDICAL CENTER	MA	$169,050
Sickle Cell Disease	NHLBI	2U54HL070585-06	0006	Family-based transition program for school-aged children with Sickle Cell Disease	BARAKAT, LAMIA	DREXEL UNIVERSITY COLLEGE OF MEDICINE	PA	$143,629
Sickle Cell Disease	NHLBI	2U54HL070585-06	0007	Omega-3 fatty acid supplementation in HbSS Disease	STUART, MARIE	THOMAS JEFFERSON UNIVERSITY	PA	$543,247
Sickle Cell Disease	NHLBI	2U54HL070585-06	7840	Administrative Core	STUART, MARIE	THOMAS JEFFERSON UNIVERSITY	PA	$163,460
Sickle Cell Disease	NHLBI	2U54HL070585-06	0008	Sickle Cell Scholar Plan	STUART, MARIE	THOMAS JEFFERSON UNIVERSITY	PA	$164,002
Sickle Cell Disease	NHLBI	2U54HL070590-06	0003	Pathogenesis & molecular epidemiology of Pneumococcal infection in Sickle Cell	TUOMANEN, ELAINE	ST. JUDE CHILDREN'S RESEARCH HOSPITAL	TN	$305,340
Sickle Cell Disease	NHLBI	2U54HL070590-06	0006	Hematopoietic stem cell gene therapy for sickle cell disease	PERSONS, DEREK	ST. JUDE CHILDREN'S RESEARCH HOSPITAL	TN	$548,197
Sickle Cell Disease	NHLBI	2U54HL070590-06	7865	Administrative Core	WARE, RUSSELL	ST. JUDE CHILDREN'S RESEARCH HOSPITAL	TN	$108,231
Sickle Cell Disease	NHLBI	2U54HL070590-06	9004	Sickle Cell Scholar component	WARE, RUSSELL	ST. JUDE CHILDREN'S RESEARCH HOSPITAL	TN	$176,137
Sickle Cell Disease	NHLBI	2U54HL070871-06	0009	Translational project: Gene therapy for Sickle Cell Disease	MALIK, PUNAM	CHILDREN'S HOSPITAL MED CTR (CINCINNATI)	OH	$562,303
Sickle Cell Disease	FIC	5R03TW007189-03		Genetic Modulation of Sickle Cell Anemia	STEINBERG, MARTIN	BOSTON UNIVERSITY MEDICAL CAMPUS	MA	$30,835
Sickle Cell Disease	NHLBI	5F31HL082037-04		Minority Predoctoral Fellowship Program	HAYWOOD, CARLTON	JOHNS HOPKINS UNIVERSITY	MD	$44,464
Sickle Cell Disease	NHLBI	5R25HL085070-03		Sickle Cell Disease Research Center (SCDRC) Summer Institute/Mentoring Program	PACE, BETTY	UNIVERSITY OF TEXAS DALLAS	TX	$280,800
Sickle Cell Disease	NINR	5R21NR009993-02		Perceptual and Cognitive Processing of Pain in Sickle Cell Disease	HOLLINS, MARK	UNIVERSITY OF NORTH CAROLINA CHAPEL HILL	NC	$212,695
Sickle Cell Disease	NHLBI	1K23HL089217-01A1		Treatment of sickle cell acute pain episodes with intravenous gammagblobulin	SHI, PATRICIA	MOUNT SINAI SCHOOL OF MEDICINE OF NYU	NY	$134,040
Sickle Cell Disease	NIDDK	5R01DK056267-08		Novel Functions of Red Cell Proteins Lu and LW	CHASIS, JOEL	UNIVERSITY OF CALIF-LAWRENC BERKELEY LAB	CA	$314,429
Sickle Cell Disease	NHLBI	1R21HL089418-01A1		Directed Evolution of Homing Endonucleases for Human Gene Therapy	ZHAO, HUIMIN	UNIVERSITY OF ILLINOIS URBANA-CHAMPAIGN	IL	$186,450
Sickle Cell Disease	NHLBI	5K02HL088026-02		Lung Endothelial Barrier Function and its Deregulation by Sickle Erythrocytes	OFORI-ACQUAH, SOLOMON	EMORY UNIVERSITY	GA	$102,711
Sickle Cell Disease	NHLBI	5K23HL076660-04		Psychobiological Reactivity in Sickle Cell Disease	TREADWELL, MARSHA	CHILDREN'S HOSPITAL & RES CTR AT OAKLAND	CA	$149,460
Sickle Cell Disease	NHLBI	5R01HL068970-08		Genetic Modulation of Sickle Cell Disease	STEINBERG, MARTIN	BOSTON UNIVERSITY MEDICAL CAMPUS	MA	$704,561
Sickle Cell Disease	NIDDK	5R21DK075731-02		Chromatin loops at the beta globin locus	BLOBEL, GERD	CHILDREN'S HOSPITAL OF PHILADELPHIA	PA	$201,513
Sickle Cell Disease	NHLBI	5U01HL078787-04		Stroke with Transfusions Changing to Hydroxyurea	WARE, RUSSELL	ST. JUDE CHILDREN'S RESEARCH HOSPITAL	TN	$3,101,582
Sickle Cell Disease	NHLBI	5R01HL079912-04		Pulmonary Hypertension and the Hypoxic Response in SCD	GORDEUK, VICTOR	HOWARD UNIVERSITY	DC	$1,843,266
Sickle Cell Disease	NHLBI	5U01HL078987-04		Stroke with Transfusions Changing to Hydroxyurea (SWITCH) Trial Data Coordinating	HELMS, RONALD	RHO FEDERAL SYSTEMS DIVISION, INC.	NC	$726,645
Sickle Cell Disease	NHLBI	5R01HL091030-02		Genomic Approaches to Improve Transfusion Therapy in SCD Patients	REID, MARION	NEW YORK BLOOD CENTER	NY	$369,500
Sickle Cell Disease	NHLBI	5R01HL079911-04		Oxyhemoglobin Desaturation and Vasculopathy in SCD	OHENE-FREMPONG, KWAKU	CHILDREN'S HOSPITAL OF PHILADELPHIA	PA	$2,018,822
Sickle Cell Disease	NIDDK	5F31DK072548-03		KLF2 and the Profile of Mouse Primitive Erythropoiesis	REDMOND, LATASHA	VIRGINIA COMMONWEALTH UNIVERSITY	VA	$39,594
Sickle Cell Disease	NHLBI	1F31HL092773-01		Hemolysis, Lipid Oxidation and Vascular Dysfunction in Sickle Cell Disease	FLEWELEN, TIMOTHY	MEDICAL COLLEGE OF WISCONSIN	WI	$31,872
Sickle Cell Disease	NHLBI	5K12HL087107-03		Clinical Hematology Research Career Development Program at Washington University	SADLER, J	WASHINGTON UNIVERSITY	MO	$386,312
Sickle Cell Disease	NHLBI	5K12HL087164-03		Clinical Hematology Research Career Development Program (K12)	NEUFELD, ELLIS	CHILDREN'S HOSPITAL BOSTON	MA	$397,073
Sickle Cell Disease	NHLBI	5K07HL081466-04		Project for Teaching Cultural Competence in Healthcare	DEGANNES, CHRISTOPHER	HOWARD UNIVERSITY	DC	$89,784
Sickle Cell Disease	NIAID	5R01AI069402-03		Assay development for high throughput screening of selectin ligand antagonists	FRENETTE, PAUL	MOUNT SINAI SCHOOL OF MEDICINE OF NYU	NY	$201,822
Sickle Cell Disease	NHLBI	5K23HL080092-04		Quality of Life Children With Sickle Cell Disease	PANEPINTO, JULIE	MEDICAL COLLEGE OF WISCONSIN	WI	$125,996
Sickle Cell Disease	NINDS	5U01NS042940-06		Silent Cerebral Infarct Multi-Center Clinical Trial -SCC	BARTON, BRUCE	MARYLAND MEDICAL RESEARCH INSTITUTE, INC	MD	$438,921
Sickle Cell Disease	NIGMS	5R01GM084614-29		BIOPHYSICAL & MOLECULAR BIOLOGICAL STUDIES OF HEMOGLOBIN	HO, CHIEN	CARNEGIE-MELLON UNIVERSITY	PA	$365,521
Sickle Cell Disease	NHGRI	5T90HG004004-03		Morehouse School of Medicine Training in Genomics and Hemoglobinopathies Program	STILES, JONATHAN	MOREHOUSE SCHOOL OF MEDICINE	GA	$1,080
Sickle Cell Disease	NHGRI	5R90HG004151-03		Morehouse School of Medicine Training in Genomics and Hemoglobinopathies Program	STILES, JONATHAN	MOREHOUSE SCHOOL OF MEDICINE	GA	$148,895
Sickle Cell Disease	NHLBI	5R25HL003679-11		Howard University Research Scientist Award	GORDEUK, VICTOR	HOWARD UNIVERSITY	DC	$301,066
Sickle Cell Disease	FIC	5T90HG004008-03		Training in the Genome Sciences and the Hemoglobinopathies	WILLARD, HUNTINGTON	DUKE UNIVERSITY	NC	$125,000
Sickle Cell Disease	NHGRI	5T90HG004008-03		Training in the Genome Sciences and the Hemoglobinopathies	WILLARD, HUNTINGTON	DUKE UNIVERSITY	NC	$923
Sickle Cell Disease	NHGRI	5R90HG004150-03		Training in the Genome Sciences and the Hemoglobinopathies	WILLARD, HUNTINGTON	DUKE UNIVERSITY	NC	$152,670
Sickle Cell Disease	NHLBI	1R01HL090632-01A1		Mechanisms of Endothelin 1-Induced Sickle Cell Pathology	RIVERA, ALICIA	CHILDREN'S HOSPITAL BOSTON	MA	$380,250
Sickle Cell Disease	NIDDK	1R01DK081290-01A1		Transactivation of Fetal Hemoglobin	PETERSON, KENNETH	UNIVERSITY OF KANSAS MEDICAL CENTER	KS	$318,750
Sickle Cell Disease	NHLBI	1R01HL090941-01A1		Hydroxyurea Pharmacokinetics and Pharmacogenomics	WARE, RUSSELL	ST. JUDE CHILDREN'S RESEARCH HOSPITAL	TN	$378,000
Sickle Cell Disease	NIDDK	1R21DK080994-01A1		The Genomic Analysis of Erythrocyte microRNA in Sickle Cell Diseases	CHI, JEN-TSAN	DUKE UNIVERSITY	NC	$191,640
Sickle Cell Disease	NIDDK	1K08DK083242-01A1		Quantitative Analysis of Blood Flow in Sickle Cell Disease	HIGGINS, JOHN	BRIGHAM AND WOMEN'S HOSPITAL	MA	$159,192
Sickle Cell Disease	NHLBI	1R21HL091265-01A1		Eptifibatide as Treatment for Acute Pain Episodes in Sickle Cell Disease	ATAGA, KENNETH	UNIVERSITY OF NORTH CAROLINA CHAPEL HILL	NC	$189,335
Sickle Cell Disease	NHLBI	2R01HL069234-06A2		Gamma Globin Induction: Molecular and Cell-Based Strategies	PACE, BETTY	UNIVERSITY OF TEXAS DALLAS	TX	$400,685
Sickle Cell Disease	NHLBI	2R42HL074579-02		Stem Cell Graft Engineering to Treat Sickle Cell Disease	ILDSTAD, SUZANNE	REGENEREX, LLC	KY	$711,438
Sickle Cell Disease	NHLBI	5P01HL044612-18	0009	Mechanisms of Vaso-Occlusion in Sickle Cell Disease	HILLERY, CHERYL	BLOODCENTER OF WISCONSIN, INC.	WI	$116,306
Sickle Cell Disease	NHLBI	5P01HL076540-05	0004	GENETIC HETEROGENEITY IN ENDOTHELIAL GENE EXPRESSION	HEBBEL, ROBERT	BETH ISRAEL DEACONESS MEDICAL CENTER	MA	$567,902
Sickle Cell Disease	NHLBI	N01HB07160-32-0-1		Pediatric Hydroxyurea Phase III Clinical Trial	NO PI IDENTIFIED	CLINICAL TRIALS AND SURVEYS CORPORATION	MD	$1,684,146
Sickle Cell Disease	NHLBI	N01HB07158-17-0-1		Pediatric Hydroxyurea Phase III Clinical Trial	NO PI IDENTIFIED			$498,315
Sickle Cell Disease	NHLBI	N01HB07157-15-0-1		Pediatric Hydroxyurea Phase III Clinical Trial	NO PI IDENTIFIED	UNIVERSITY OF MIAMI SCHOOL OF MEDICINE	FL	$311,500
Sickle Cell Disease	NHLBI	N01HB07154-21-0-1		Pediatric Hydroxyurea Phase III Clinical Trial	NO PI IDENTIFIED	MEDICAL UNIVERSITY OF SOUTH CAROLINA	SC	$230,396
Sickle Cell Disease	NHLBI	N01HB07153-17-0-1		Pediatric Hydroxyurea Phase III Clinical Trial	NO PI IDENTIFIED	JOHNS HOPKINS UNIVERSITY	MD	$389,122
Sickle Cell Disease	NHLBI	N01HB07151-17-0-1		Pediatric Hydroxyurea Phase III Clinical Trial	NO PI IDENTIFIED	DUKE UNIVERSITY	NC	$270,293
Sickle Cell Disease	NHLBI	N01HB07150-16-0-1		Pediatric Hydroxyurea Phase III Clinical Trial	NO PI IDENTIFIED	CHILDREN'S RESEARCH INSTITUTE	DC	$441,961
Sickle Cell Disease	NHLBI	5P01HL032262-27	0016	Role of zfp148 (ZBP-89) in Erythroid Development	CANTOR, ALAN	CHILDREN'S HOSPITAL BOSTON	MA	$200,007
Sickle Cell Disease	NIGMS	5S06GM008016-38	0114	Iron Chelators: Role in Sickle Cell Malaria (pilot)	WALCOURT, ASIKIYA	HOWARD UNIVERSITY	DC	$64,185
Sickle Cell Disease	NHLBI	5P01HL066299-08	0004	T-type Calcium Channels and von Willebrand Factor Release	WU, SONGWEI	UNIVERSITY OF SOUTH ALABAMA	AL	$272,427
Sickle Cell Disease	NHLBI	N01HB67189-3-0-1		Phase II/III Trial-Sildenafil for Sickle Cell Disease-Assoc. Pulm. Hypertension	NO PI IDENTIFIED	HOWARD UNIVERSITY	DC	$308,392
Sickle Cell Disease	NHLBI	N01HB67188-2-0-1		Phase II/III Trial-Sildenafil for Sickle Cell Disease-Assoc. Pulm. Hypertension	NO PI IDENTIFIED	JOHNS HOPKINS UNIVERSITY	MD	$228,891
Sickle Cell Disease	NHLBI	N01HB67187-3-0-1		Phase II/III Trial-Sildenafil for Sickle Cell Disease-Assoc. Pulm. Hypertension	NO PI IDENTIFIED	UNIVERSITY OF ILLINOIS AT CHICAGO	IL	$344,995
Sickle Cell Disease	NHLBI	N01HB67186-2-0-1		Phase II/III Trial-Sildenafil for Sickle Cell Disease-Assoc. Pulm. Hypertension	NO PI IDENTIFIED	CHILDREN'S HOSPITAL & RES CTR AT OAKLAND	CA	$366,202
Sickle Cell Disease	NHLBI	N01HB67185-2-0-1		Phase II/III Trial-Sildenafil for Sickle Cell Disease-Assoc. Pulm. Hypertension	NO PI IDENTIFIED	UNIVERSITY OF COLORADO DENVER	CO	$385,356
Sickle Cell Disease	NHLBI	N01HB67184-3-0-1		Phase II/III Trial-Sildenafil for Sickle Cell Disease-Assoc. Pulm. Hypertension	NO PI IDENTIFIED	CHILDREN'S HOSP PITTSBURGH/UPMC HLTH SYS	PA	$182,089
Sickle Cell Disease	NHLBI	N01HB07159-20-0-1		Pediatric Hydroxyurea Phase III Clinical Trial	NO PI IDENTIFIED	UNIVERSITY OF TEXAS SW MED CTR/DALLAS	TX	$905,218
Sickle Cell Disease	NHLBI	N01HB07156-15-0-1		Pediatric Hydroxyurea Phase III Clinical Trial	NO PI IDENTIFIED	SUNY DOWNSTATE MEDICAL CENTER	NY	$74,170
Sickle Cell Disease	NHLBI	N01HB07155-16-0-1		Pediatric Hydroxyurea Phase III Clinical Trial	NO PI IDENTIFIED	ST. JUDE CHILDREN'S RESEARCH HOSPITAL	TN	$456,619
Sickle Cell Disease	NHLBI	N01HB07152-18-0-1		Pediatric Hydroxyurea Phase III Clinical Trial	NO PI IDENTIFIED	HOWARD UNIVERSITY	DC	$311,476
Sickle Cell Disease	NHGRI	3R01HL077765-03S1		RBC Ion Transporters as Hemoglobinopathy Risk Modifiers	ALPER, SETH	BETH ISRAEL DEACONESS MEDICAL CENTER	MA	$7,407
Sickle Cell Disease	NHLBI	3R01HL077765-03S1		RBC Ion Transporters as Hemoglobinopathy Risk Modifiers	ALPER, SETH	BETH ISRAEL DEACONESS MEDICAL CENTER	MA	$14,906
Sickle Cell Disease	NHLBI	N01HB67183-3-0-1		Phase II/III Trial-Sildenafil for Sickle Cell Disease-Assoc. Pulm. Hypertension	NO PI IDENTIFIED	U OF L IMPERIAL COL OF SCI/TECHNLGY/MED	UK	$559,538
Sickle Cell Disease	NHLBI	N01HB67190-2-0-1		Phase II/III Trial-Sildenafil for Sickle Cell Disease-Assoc. Pulm. Hypertension	NO PI IDENTIFIED	YESHIVA UNIVERSITY	NY	$396,788
Sickle Cell Disease	NHLBI	5P01HL053749-15	0006	In Vivo Selection of Transduced Hematopoietic Stem Cells	SORRENTINO, BRIAN	ST. JUDE CHILDREN'S RESEARCH HOSPITAL	TN	$305,351
Sickle Cell Disease	NHLBI	5P01HL053749-15	0011	Factors modulating gamma globin gene expression	CUNNINGHAM, JOHN	ST. JUDE CHILDREN'S RESEARCH HOSPITAL	TN	$400,762
Sickle Cell Disease	NHLBI	5P01HL053749-15	9003	CORE--ANIMAL MODELS	SORRENTINO, BRIAN	ST. JUDE CHILDREN'S RESEARCH HOSPITAL	TN	$466,052
Sickle Cell Disease	NHLBI	5P01HL053750-15	0008	Globin LCR containing Adeno-AAV Vectors	LIEBER, ANDRE	UNIVERSITY OF WASHINGTON	WA	$250,400
Sickle Cell Disease	NHLBI	3R01HL078536-03S1		Computerized PAINRelievelt for Adult Sickle Cell Disease	WILKIE, DIANA	UNIVERSITY OF ILLINOIS AT CHICAGO	IL	$153,400
Sickle Cell Disease	NIAMS	5P30AR050948-05	0010	Human Induced Pluripotent Stem Cells To Investigate Inherited Skin Diseases	CHOW, LOUISE	UNIVERSITY OF ALABAMA AT BIRMINGHAM	AL	$45,218
Sickle Cell Disease	NHLBI	N01HB67182-3-0-1		Phase II/III Trial-Sildenafil for Sickle Cell Disease-Assoc. Pulm. Hypertension	NO PI IDENTIFIED	RHO FEDERAL SYSTEMS DIVISION, INC.	NC	$696,220
Sickle Cell Disease	NHLBI	Y1HB3005-8-0-1		Pediatric Hydroxyurea (BABY HUG) Drug Distribution Center	NO PI IDENTIFIED			$43,500
Sickle Cell Disease	NCRR	5P51RR000169-47	5713	FETAL MONKEY MODEL FOR GENE THERAPY FOR SICKLE CELL DISEASE	KAN, YUET	UNIVERSITY OF CALIFORNIA DAVIS	CA	$26,827
Sickle Cell Disease	NIA	5P51RR000169-47	5713	FETAL MONKEY MODEL FOR GENE THERAPY FOR SICKLE CELL DISEASE	KAN, YUET	UNIVERSITY OF CALIFORNIA DAVIS	CA	$284
Sickle Cell Disease	NCRR	5P51RR013986-10	6216	GENETIC MODIFIERS OF SEVERITY IN SICKLE CELL DISEASE	PLATT, ORAH	SOUTHWEST FOUNDATION FOR BIOMEDICAL RES	TX	$147,565
Sickle Cell Disease	NCRR	2M01RR000043-48	6857	HUMAN MODELS OF SICKLE CELL VASCULAR DAMAGE	COATES, THOMAS	UNIVERSITY OF SOUTHERN CALIFORNIA	CA	$45,667
Sickle Cell Disease	NCRR	2M01RR000046-48	6872	PREVALENCE OF PULMONARY HYPERTENSION IN SICKLE CELL DISEASE	ATAGA, KENNETH	UNIVERSITY OF NORTH CAROLINA CHAPEL HILL	NC	$2,449
Sickle Cell Disease	NCRR	2M01RR000046-48	6905	PRIAPISM IN BOYS AND MEN: INCIDENCE AND PREVENTION	REDDING-LALLINGER, RUPA	UNIVERSITY OF NORTH CAROLINA CHAPEL HILL	NC	$1,836
Sickle Cell Disease	NCRR	2M01RR000046-48	6907	EFFECT OF HYDROXYUREA ON BLOOD COAGULATION IN PATIENT WITH SICKLE CELL DISEASE	ATAGA, KENNETH	UNIVERSITY OF NORTH CAROLINA CHAPEL HILL	NC	$459
Sickle Cell Disease	NCRR	2M01RR000046-48	6913	CLINICAL TRIAL: ARGININE SUPPLEMENTATION IN SICKLE CELL ANEMIA: PHYSIOLOGICAL A	ATAGA, KENNETH	UNIVERSITY OF NORTH CAROLINA CHAPEL HILL	NC	$1,071
Sickle Cell Disease	NCRR	2M01RR000046-48	6939	CLINICAL TRIAL: NEUROPSYCHOLOGICAL DYSFUNCTION AND NEUROIMAGING ABNORMALITIES IN	ORRINGER, EUGENE	UNIVERSITY OF NORTH CAROLINA CHAPEL HILL	NC	$2,372
Sickle Cell Disease	NCRR	2M01RR000046-48	6942	CLINICAL TRIAL: PHASE III, ICA-17043 WITH OR WITHOUT HYDROXYUREA IN SICKLE CELL	ATAGA, KENNETH	UNIVERSITY OF NORTH CAROLINA CHAPEL HILL	NC	$1,377
Sickle Cell Disease	NCRR	2M01RR000046-48	6982	CLINICAL TRIAL: BOSENTAN IN PATIENTS WITH SYMPTOMATIC PULMONARY HYPERTENSION & S	ATAGA, KENNETH	UNIVERSITY OF NORTH CAROLINA CHAPEL HILL	NC	$230
Sickle Cell Disease	NCRR	2M01RR000046-48	6983	CLINICAL TRIAL: BOSENTAN IN SICKLE CELL PATIENTS WITH SYMPTOMATIC PULMONARY HYPE	ATAGA, KENNETH	UNIVERSITY OF NORTH CAROLINA CHAPEL HILL	NC	$230
Sickle Cell Disease	NCRR	2M01RR000046-48	6987	CLINICAL TRIAL: LONGTERM SAFETY OF ICA-17043 WITH OR WITHOUT HYDROXYUREA IN SICK	ATAGA, KENNETH	UNIVERSITY OF NORTH CAROLINA CHAPEL HILL	NC	$1,454
Sickle Cell Disease	NCRR	2M01RR000046-48	7017	PULMONARY HYPERTENSION IN SICKLE CELL DISEASE WITH IDENTIFICATION OF CLINICAL AS	ATAGA, KENNETH	UNIVERSITY OF NORTH CAROLINA CHAPEL HILL	NC	$76
Sickle Cell Disease	NCRR	2M01RR000046-48	7021	CLINICAL TRIAL: IMPACTS TRIAL: INVESTIGATION OF THE MODULATION OF PHOSPHOLIPASE	ATAGA, KENNETH	UNIVERSITY OF NORTH CAROLINA CHAPEL HILL	NC	$76
Sickle Cell Disease	NCRR	2M01RR000046-48	7037	6R-BH4 IN SUBJECTS WITH SICKLE CELL DISEASE	ATAGA, KENNETH	UNIVERSITY OF NORTH CAROLINA CHAPEL HILL	NC	$842
Sickle Cell Disease	NCRR	2M01RR000046-48	7048	SENSORY AND PERCEPTUAL PROCESSING IN SICKLE CELL DISEASE	HOLLINS, MARK	UNIVERSITY OF NORTH CAROLINA CHAPEL HILL	NC	$76
Sickle Cell Disease	NCRR	5M01RR000065-46	7140	NON-INVASIVE MICROCIRCULATORY MONITORING IN SICKLE CELL DISEASE	AISIKU, IMO	VIRGINIA COMMONWEALTH UNIVERSITY	VA	$3,792
Sickle Cell Disease	NCRR	5M01RR020359-04	7277	PEDIATRIC HYDROXYUREA PHASE III CLINICAL TRIAL: BABY HUG	MINNITI, CATERINA	CHILDREN'S RESEARCH INSTITUTE	DC	$118,427
Sickle Cell Disease	NCRR	5M01RR020359-04	7282	SILENT CEREBRAL INFARCT MULTI-CENTER TRIAL	MINNITI, CATERINA	CHILDREN'S RESEARCH INSTITUTE	DC	$56,818
Sickle Cell Disease	NCRR	5M01RR020359-04	7313	PULMONARY HYPERTENSION AND THE HYPOXIC RESPONSE IN SICKLE CELL DIESEASE:	MINNITI, CATERINA	CHILDREN'S RESEARCH INSTITUTE	DC	$43,126
Sickle Cell Disease	NCRR	5M01RR000425-39	7362	CLINICAL TRIAL: L-GLUTAMINE THEREPY FOR SICKLE CELL ANEMIA	NIIHARA, YUTAKA	LA BIOMED RES INST/ HARBOR UCLA MED CTR	CA	$10,964
Sickle Cell Disease	NCRR	5M01RR000425-39	7366	CLINICAL TRIAL: L-GLUTAMINE THERAPY FOR SICKLE CELL ANEMIA	NIIHARA, YUTAKA	LA BIOMED RES INST/ HARBOR UCLA MED CTR	CA	$28,507
Sickle Cell Disease	NCRR	5M01RR012248-12	7712	SICKLE CELL	NAGEL, RONALD	YESHIVA UNIVERSITY	NY	$7,850
Sickle Cell Disease	NCRR	5M01RR008084-15	7914	CLINICAL TRIAL: NEUROPSYCHOLOGICAL DYSFUNCTION/NEUROIMAGING ABNORMALITIES IN ADU	KALINYAK, KAREN	CHILDREN'S HOSPITAL MED CTR (CINCINNATI)	OH	$2,080
Sickle Cell Disease	NCRR	5M01RR000071-45	8295	CLINICAL TRIAL: TREATMENT OF SICKLE CELL VASO-OCCLUSIVE CRISIS WITH HIGH DOSE IV	FRENETTE, PAUL	MOUNT SINAI SCHOOL OF MEDICINE OF NYU	NY	$570
Sickle Cell Disease	NCRR	5M01RR010284-13	5205	CLINICAL TRIAL: ICL670	GORDEUK, VICTOR	HOWARD UNIVERSITY	DC	$39,983
Sickle Cell Disease	NCRR	5M01RR010284-13	5214	PUSH	GORDEUK, VICTOR	HOWARD UNIVERSITY	DC	$143,912
Sickle Cell Disease	NCRR	5M01RR010284-13	5217	CLINICAL TRIAL: HYDROXYUREA	ONYEKWERE, ONYINYE	HOWARD UNIVERSITY	DC	$8,658
Sickle Cell Disease	NCRR	5M01RR010284-13	5218	CLINICAL TRIAL: INOT36	ONYEKWERE, ONYINYE	HOWARD UNIVERSITY	DC	$26,619
Sickle Cell Disease	NCRR	5M01RR010284-13	5225	B12	LOMBARDO, FREDRIC	HOWARD UNIVERSITY	DC	$99,495
Sickle Cell Disease	NCRR	2M01RR018535-06	5492	HMGB-1 ACCUMULATION IN PATIENTS WITH SICKLE CELL DISEASE	BARGINEAR, MYRA	FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH	NY	$91,020
Sickle Cell Disease	NCRR	5M01RR000051-47	5744	ARGININE SUPPLEMNTATN IN SICKLE CELL ANEMIA:PHYSIOLOGICAL & PROPHYLACTIC EFFECTS	HASSELL, KATHRYN	UNIVERSITY OF COLORADO DENVER	CO	$1,384
Sickle Cell Disease	NCRR	5P41RR001209-29	7934	INTERMOLECULAR INTERACTION OF HEMOGLOBIN AND SICKLED HEMOGLOBIN	TSURUTA, HIROTSUGU	STANFORD UNIVERSITY	CA	$1,146
Sickle Cell Disease	NCRR	5P41RR010888-12	5241	COMPARATIVE PROTEOMICS OF SICKLE CELL DISEASE-RELATED PULMONARY HYPERTENSION	KLINGS, ELIZABETH	BOSTON UNIVERSITY MEDICAL CAMPUS	MA	$3,237
Sickle Cell Disease	NCRR	5U54RR022814-04	6882	MOREHOUSE CCRE PP1- ENDOTHELIAL PROGENITOR CELLS IN SICKLE CELL DISEASE	GIBBONS, GARY	MOREHOUSE SCHOOL OF MEDICINE	GA	$44,670
Sickle Cell Disease	NIA	N01AG12109-11-0-5		Gene-finding & Longitudinal Studies for Age-Asso. Conditions in a Sardinian Pop.	NO PI IDENTIFIED			$2,251,212
Sickle Cell Disease	NHLBI	5P01HL055552-12	0001	Endothelial Biology	HEBBEL, ROBERT	UNIVERSITY OF MINNESOTA TWIN CITIES	MN	$382,210
Sickle Cell Disease	NHLBI	5P01HL055552-12	0002	Renal Vascular Injury	NATH, KARL	UNIVERSITY OF MINNESOTA TWIN CITIES	MN	$350,295
Sickle Cell Disease	NHLBI	5P01HL055552-12	0003	heme oxygenase 1 & Stasis	VERCELLOTTI, GREGORY	UNIVERSITY OF MINNESOTA TWIN CITIES	MN	$438,460
Sickle Cell Disease	NCRR	3M01RR000095-47S1	8318	METABOLIC CONSEQUENCE OF SICKLE CELL ANEMIA IN ADOLESCENCE	BUCHOWSKI, MACIEJ	VANDERBILT UNIVERSITY	TN	$422
Sickle Cell Disease	NCRR	3M01RR000095-47S1	8319	METABOLIC CONSEQUENCES OF ERYTHROCYTE TRANSFUSION IN SICKLE CELL ANEMIA	BUCHOWSKI, MACIEJ	VANDERBILT UNIVERSITY	TN	$211
Sickle Cell Disease	NCRR	3M01RR000095-47S1	8443	PROTEIN REQUIREMENT IN SICKLE CELL ANEMIA	BUCHOWSKI, MACIEJ	VANDERBILT UNIVERSITY	TN	$316
Sickle Cell Disease	NIA	1Z01AG000675-02		Aging-related Traits and Disease Risk Factors in a Sardinian Population Cohort	SCHLESSINGER, DAVID	NIH		$419,539
Sickle Cell Disease	NIDDK	1Z01DK025016-34		Pharmacological Control Of Human Hemoglobin Gene Expression	SCHECHTER, ALAN	NIH		$131,459
Sickle Cell Disease	NIDDK	1Z01DK025021-33		Globin Gene Expression And Treatment Of Sickle Cell Anemia	NOGUCHI, CONSTANCE	NIH		$263,223
Sickle Cell Disease	NIDDK	1Z01DK025093-10		Nitric Oxide Transport By Hemoglobin	SCHECHTER, ALAN	NIH		$394,378
Sickle Cell Disease	NIDDK	1Z01DK025100-02		Diagnosis and Treatment of Iron Overload.	MILLER, JEFFERY	NIH		$374,632
Sickle Cell Disease	NIDDK	1Z01DK025101-02		Regulation of Fetal Hemoglobin Production in Humans.	MILLER, JEFFERY	NIH		$374,632
Sickle Cell Disease	NIDDK	1Z01DK025104-02		Clinical Applications of Nitrite	SCHECHTER, ALAN	NIH		$350,559
Sickle Cell Disease	NIDDK	1Z01DK029053-02		Screening for a Drug for Sickle Cell Disease	EATON, WILLIAM	NIH		$395,297
Sickle Cell Disease	NIDDK	1Z01DK043308-13		Focal Segmental Glomerulosclerosis: Genetics & Mechanisms	KOPP, JEFFREY	NIH		$520,944
Sickle Cell Disease	NIDDK	1Z01DK075008-03		Investigation of non-cirrhotic portal hypertension.	HELLER, THEO	NIH		$448,652
Sickle Cell Disease	NIBIB	1Z01EB000059-01		Infrared Imaging to Assesss Endothelial Function in Sickle Cell Disease Patients	GORBACH, ALEXANDER	NIH		$53,092
Sickle Cell Disease	NIBIB	1Z01EB000060-01		Design of Infrared Imaging to Assess Vascular Tone in Peripheral Vascular Beds	GORBACH, ALEXANDER	NIH		$26,504
Sickle Cell Disease	NHGRI	1Z01HG200339-02		Red Cell Biology	BODINE, DAVID	NIH		$864,857
Sickle Cell Disease	NHLBI	1Z01HL005074-03		Use of Bosentan in Patients with Symptomatic PH Associated with SCD	MACHADO, ROBERTO	NIH		$63,460
Sickle Cell Disease	NHLBI	1Z01HL005075-03		Prevalence of PAH in SCD Patients in Nigeria	GLADWIN, MARK	NIH		$954,218
Sickle Cell Disease	NHLBI	1Z01HL005110-04		Multicenter Trial of NO for Acute Treatment of Sickle Cell Pain Episodes	GLADWIN, MARK	NIH		$1,228,440
Sickle Cell Disease	NHLBI	1Z01HL005116-02		Treatment of PH and SCD with Sildenafil Therapy	MACHADO, ROBERTO	NIH		$699,914
Sickle Cell Disease	NHLBI	1Z01HL005802-03		Synergy of Hydroxyurea and Erythropoietin on Fetal Hemoglobin in SCD	GLADWIN, MARK	NIH		$635,991
Sickle Cell Disease	NHLBI	1Z01HL005803-03		Use of Hydroxyurea & L-arginine or Sildenafil in Patients w/Sickle Cell Disease	GLADWIN, MARK	NIH		$31,962
Sickle Cell Disease	NIDDK	1Z01HL006003-01		Effects Of Thalidomide and Stem Cell Factor On Fetal Hemoglobin Synthesis	RODGERS, GRIFFIN	NIH		$274,625
Sickle Cell Disease	NIDDK	1Z01HL006006-01		Cloning And Characterization Of A Hydroxyurea-inducible Gene	RODGERS, GRIFFIN	NIH		$274,625
Sickle Cell Disease	NIDDK	1Z01HL006007-01		Nonmyeloablative allogeneic PBSC in globin disorders	TISDALE, JOHN	NIH		$384,475
Sickle Cell Disease	NIDDK	1Z01HL006008-01		A preclinical large animal model for globin gene transfer	TISDALE, JOHN	NIH		$329,550